Cg Oncology Inc (CGON)

Mar 12, 2025

CG Oncology to Participate in the 40th Annual European Association of Urology Congress with a Series of Key Presentations and Updates - The Manila Times

Mar 12, 2025

Mar 12, 2025

CG Oncology to Present Late-Breaking Abstract and Key Research on Cretostimogene Grenadenorepvec at 40th Annual EAU Congress - Nasdaq

Mar 12, 2025

Mar 12, 2025

Major Clinical Trial Results: CG Oncology Unveils New Bladder Cancer Treatment Data at European Congress - StockTitan

Mar 12, 2025

Mar 09, 2025

CG Oncology (NASDAQ:CGON) Earns Overweight Rating from Morgan Stanley - Defense World

Mar 09, 2025

Mar 07, 2025

3 Analysts Assess CG Oncology: What You Need To Know - Benzinga

Mar 07, 2025

Mar 07, 2025

Oncolytic Adenovirus Market Set to Grow Substantially Through 2032, DelveInsight Projects | CG Oncology, Orca Therapeutics B.V., Syneos Health, DNAtrix, Inc. - Barchart

Mar 07, 2025

Mar 07, 2025

Oncolytic Adenovirus Market Set to Grow Substantially Through - openPR

Mar 07, 2025

Mar 06, 2025

ImmunityBio Analyst Predicts Strong 2025 For New Bladder Cancer Drug - Benzinga

Mar 06, 2025

Mar 05, 2025

New York State Common Retirement Fund Grows Stock Position in CG Oncology, Inc. (NASDAQ:CGON) - Defense World

Mar 05, 2025

Mar 04, 2025

Cg Oncology Inc (CGON) is looking forward to a strong quarter - SETE News

Mar 04, 2025

Mar 04, 2025

CG Oncology stock hits 52-week low at $24.15 amid challenges - Investing.com India

Mar 04, 2025

Mar 04, 2025

CG Oncology, Inc. (NASDAQ:CGON) Shares Bought by Rhumbline Advisers - Defense World

Mar 04, 2025

Feb 26, 2025

CG Oncology to Present at the TD Cowen 45th Annual Health Care Conference - The Manila Times

Feb 26, 2025

Feb 26, 2025

Can CG Oncology's CEO Presentation Reveal New Bladder Cancer Treatment Progress? - StockTitan

Feb 26, 2025

Feb 25, 2025

CG Oncology Enters Oversold Territory (CGON) - Nasdaq

Feb 25, 2025

Feb 25, 2025

CG Oncology stock hits 52-week low at $25.71 amid challenges - Investing.com Canada

Feb 25, 2025

Feb 25, 2025

Is CG Oncology, Inc. (CGON) An Oversold Biotech Stock to Buy Now? - Insider Monkey

Feb 25, 2025

Feb 24, 2025

IPOs Numbers Rise In 2024, But Dwindling Returns Could Diminish Potential In 2025 - Scrip

Feb 24, 2025

Feb 24, 2025

IPOs Numbers Rise In 2024 But Dwindling Returns Could Diminish Potential In 2025 - Citeline News & Insights

Feb 24, 2025

Feb 24, 2025

Critical Analysis: Novozymes A/S (OTCMKTS:NVZMY) vs. CG Oncology (NASDAQ:CGON) - Defense World

Feb 24, 2025

Feb 23, 2025

Why CG Oncology, Inc. (CGON) is the Most Oversold Pharma Stock to Buy According to Analysts - Insider Monkey

Feb 23, 2025

Feb 23, 2025

Valneva (NASDAQ:VALN) and CG Oncology (NASDAQ:CGON) Head-To-Head Review - Defense World

Feb 23, 2025

Feb 20, 2025

UroGen Plots Expansion, Brings In A New Asset - Citeline News & Insights

Feb 20, 2025

Feb 20, 2025

Why CG Oncology (CGON) Is the Most Oversold Healthcare Stock to Buy Now - Insider Monkey

Feb 20, 2025

Feb 19, 2025

12 Most Oversold Healthcare Stocks to Buy Now - Insider Monkey

Feb 19, 2025

Feb 18, 2025

CG Oncology, Inc. (NASDAQ:CGON) Given Consensus Rating of “Buy” by Analysts - Defense World

Feb 18, 2025

Feb 17, 2025

Contrasting OKYO Pharma (NASDAQ:OKYO) and CG Oncology (NASDAQ:CGON) - Defense World

Feb 17, 2025

Feb 15, 2025

Mirae Asset Global Investments Co. Ltd. Buys Shares of 2,254 CG Oncology, Inc. (NASDAQ:CGON) - Defense World

Feb 15, 2025

Feb 06, 2025

China Universal Asset Management Co. Ltd. Acquires New Position in CG Oncology, Inc. (NASDAQ:CGON) - MarketBeat

Feb 06, 2025

Feb 06, 2025

Market Watch Highlights: Cg Oncology Inc (CGON) Ends on an Upturn Note at 30.32 - The Dwinnex

Feb 06, 2025

Feb 06, 2025

CGON Stock Sees Surge of Approximately 0.10% in Last Five Days - Knox Daily

Feb 06, 2025

Feb 03, 2025

CG Oncology, Inc. (NASDAQ:CGON) is a favorite amongst institutional investors who own 62% - Yahoo Finance

Feb 03, 2025

Feb 01, 2025

Reviewing Cardiol Therapeutics (NASDAQ:CRDL) and CG Oncology (NASDAQ:CGON) - Defense World

Feb 01, 2025

Jan 31, 2025

Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Jan 31, 2025

Jan 25, 2025

CG Oncology, Inc. (NASDAQ:CGON) Stock Holdings Boosted by JPMorgan Chase & Co. - Defense World

Jan 25, 2025

Jan 25, 2025

CG Oncology, Inc. (NASDAQ:CGON) Shares Purchased by JPMorgan Chase & Co. - MarketBeat

Jan 25, 2025

Jan 24, 2025

Analysts Offer Predictions for CG Oncology FY2025 Earnings - Defense World

Jan 24, 2025

Jan 24, 2025

CG Oncology, Inc. (NASDAQ:CGON) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat

Jan 24, 2025

Jan 24, 2025

CG Oncology, Inc. (NASDAQ:CGON) Receives Average Recommendation of “Buy” from Analysts - Defense World

Jan 24, 2025

Jan 23, 2025

Cantor Fitzgerald Comments on CG Oncology FY2025 Earnings - MarketBeat

Jan 23, 2025

Jan 21, 2025

Oncolytic Virus Cancer Therapy Pipeline 2024: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight | CG Oncology, Targovax, Transgene, Istari Oncology, Targovax, Oncolytics Biotech - The Globe and Mail

Jan 21, 2025

Jan 21, 2025

Oncolytic Virus Cancer Therapy Pipeline 2024: Therapies, MOA - openPR

Jan 21, 2025

Jan 21, 2025

This CG Oncology Insider Reduced Their Stake By 16% - Simply Wall St

Jan 21, 2025

Jan 17, 2025

Does CG Oncology, Inc. (CGON) Have the Potential to Rally 123.34% as Wall Street Analysts Expect? - MSN

Jan 17, 2025

Jan 16, 2025

Cg Oncology Inc (CGON) Volatility Hits 4.53%: What Good Investors Need To Be Aware Of - Stocks Register

Jan 16, 2025

Jan 15, 2025

Cg oncology director Leonard Post sells shares worth $29,660 By Investing.com - Investing.com Australia

Jan 15, 2025

Jan 14, 2025

Cg oncology director Leonard Post sells shares worth $29,660 - Investing.com India

Jan 14, 2025

Jan 14, 2025

CG Oncology, Inc. (NASDAQ:CGON) Director Leonard E. Post Sells 1,000 Shares - MarketBeat

Jan 14, 2025